find the latest legal job
Part Time Risk & Compliance Officer
Category: Other | Location: Brisbane QLD 4000
· Brisbane City · Flexible Part Time Hours
View details
Infrastructure Lawyer/SA
Category: Construction Law | Location: Sydney CBD, Inner West & Eastern Suburbs Sydney NSW
· Global elite law firm · Dedicated Infrastructure team
View details
Property Lawyer
Category: Property Law | Location: All Melbourne VIC
· 12 Month Contract · Diverse Work
View details
Family Lawyer
Category: Family Law | Location: Eastern Suburbs Melbourne VIC
· Boutique Firm · Great Reputation
View details
Infrastructure Lawyers
Category: Construction Law | Location: All Perth WA
· We'd be particularly interested to hear from you if you were a lawyer who knows your way around the infrastructure and energy sectors.
View details
Deacons in Greek drug company IPO

Deacons in Greek drug company IPO

Deacons advised Genepharm Australasia on its IPO, its debut on the Australian Stock Exchange raising $12 million from the issue of 24 million 50-cent shares.The local arm of privately owned…

Deacons advised Genepharm Australasia on its IPO, its debut on the Australian Stock Exchange raising $12 million from the issue of 24 million 50-cent shares.

The local arm of privately owned Greek pharmaceuticals giant, the Genepharm Group, Deacons said Genepharm Australasia’s shares began trading on 10 June at a premium of more than 30 per cent to their issue price and finished their first trading day strongly, 18 per cent above the issue price.

Genepharm Australasia is a specialist pharmaceutical company that will develop, market and distribute a “premium range” of generic pharmaceuticals throughout Australia and NZ. These will include some of the newest and highest-value Pharmaceutical Benefits Scheme (PBS) products. The company also plans to expand into Asia.

The funds raised from the IPO will be spent to register up to 50 generic drugs, including a number of those that are funded by the PBS and will be released from patent protection by 2008.

Deacons Melbourne corporate and commercial partners Rod Lyle and Bernard O’Shea and senior associate Stephen Blank led the Deacons team.

They worked closely with Genepharm CEO Dennis Bastas and CFO Kip Harding, Ernst&Young and lead manager/underwriter ABN AMRO Morgans, to bring about the listing within three months of receiving initial instructions.

During due diligence, several members of the transaction team visited the Genepharm Group head office and manufacturing plant in Athens.

“The Genepharm offering was underpinned by the group’s commitment to global expansion,” Rod Lyle said.

“We were impressed with the operations and manufacturing capabilities demonstrated by the Genepharm Group in Greece and we look forward to assisting Genepharm Australasia with growing its business in Australia and NZ and expansion into Asia.”

According to Deacons, Genepharm has plans to become a major player in Australia’s generic drugs market.

At close of trading on the day of Genepharm’s ASX debut, the company’s market capitalisation was approximately $45 million.

Like this story? Read more:

QLS condemns actions of disgraced lawyer as ‘stain on the profession’

NSW proposes big justice reforms to target risk of reoffending

The legal budget breakdown 2017

Deacons in Greek drug company IPO
lawyersweekly logo
Promoted content
Recommended by Spike Native Network
more from lawyers weekly
Nov 17 2017
It's time for politicians to commit to eradicating domestic violence
The national shame of domestic violence cannot be left unaddressed, writes Christine Smyth. ...
Nov 16 2017
From lawyer in law firm to senior governance professional
Promoted by Governance Institute of Australia As a law graduate, Kate Griffiths never imagined...
marriage equality
Nov 16 2017
Legislation the next hurdle for marriage equality
Lawyers have underscored the importance of ensuring same-sex marriage legislation does not limit ant...
Allens managing partner Richard Spurio, image courtesy Allens' website
Jun 21 2017
Promo season at Allens
A group of lawyers at Allens have received promotions across its PNG and Australian offices. ...
May 11 2017
Partner exits for in-house role
A Victorian lawyer has left the partnership of a national firm to start a new gig with state governm...
Esteban Gomez
May 11 2017
National firm recruits ‘major asset’
A national law firm has announced it has appointed a new corporate partner who brings over 15 years'...
Nicole Rich
May 16 2017
Access to justice for young transgender Australians
Reform is looming for the process that young transgender Australians and their families must current...
Geoff Roberson
May 11 2017
The lighter side of the law: when law and comedy collide
On the face of it, there doesn’t seem to be much that is amusing about the law, writes Geoff Rober...
May 10 2017
Advocate’s immunity – without fear or without favour but not both
On 29 March 2017, the High Court handed down its decision in David Kendirjian v Eugene Lepore & ...